ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yelin, E.
Right arrow Articles by Blanc, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yelin, E.
Right arrow Articles by Blanc, P.
Eur Respir J 2002; 19:414-421
Copyright ©ERS Journals Ltd 2002


A national study of medical care expenditures for respiratory conditions

E. Yelin1,2, L. Trupin2, M. Cisternas3, M. Eisner1, P. Katz2 and P. Blanc1

1 Division of Occupational and Environmental Medicine, 2 Division of Rheumatology, Dept of Medicine, University of California and 3 MGC Data Services, San Francisco, USA

CORRESPONDENCE: E. Yelin, UCSF Box 0920, San Francisco, California, 94143-0920, USA. Fax: 1 4154769030. E-mail: yelin2@itsa.ucsf.edu

Keywords: cost of illness, economics, respiratory conditions

Received: September 16, 2001
Accepted September 19, 2001

This study was supported by Grant NHLBI R01 HL56438.

This study was undertaken to estimate the magnitude of medical care expenditures among persons with respiratory conditions in the USA in 1996, and the increment in expenditures attributable to these conditions.

The study data were derived from the 1996 Medical Expenditure Panel Survey, a national sample of 21,571 persons. Of the 21,571, 1,027 reported one or more respiratory condition. After weighting, the individuals may represent about 12.1 million persons in the USA. All medical care expenditures of these individuals were tabulated, stratified by comorbidity status, and then compared to those among persons with nonrespiratory conditions or with no conditions. Regression techniques were then used to estimate the increment of healthcare expenditures attributable to the respiratory conditions.

From a national total of $45.3 billion, medical care expenditures averaged $3,753 among persons with respiratory conditions. Hospital stays comprised the largest component (45%). The per capita increment in total expenditures attributable to respiratory conditions ranged from $1,003–2,588, from a national total ranging from $12.1–31.3 billion.

The total medical care expenditure of persons with respiratory conditions was estimated to be $45.3 billion, of which $12.1–31.3 billion represents an increment in expenditures associated with the conditions themselves.




This article has been cited by other articles:


Home page
FASEB J.Home page
R. L. Nahin
Identifying and pursuing research priorities at the National Center for Complementary and Alternative Medicine
FASEB J, August 1, 2005; 19(10): 1209 - 1215.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. H. Howard and J. E. McGowan Jr
Initial and Follow-up Costs by Treatment Outcome for Children With Respiratory Infections
Pediatrics, May 1, 2004; 113(5): 1352 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
J. W. Cohen and N. A. Krauss
Spending And Service Use Among People With The Fifteen Most Costly Medical Conditions, 1997
Health Aff., March 1, 2003; 22(2): 129 - 138.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the European Respiratory Society.